Bangladeshi Firms Roll Out Harvoni Generic At $12-13
This article was originally published in PharmAsia News
Executive Summary
Bangladeshi firms Incepta and Beximco have now introduced what are probably the first cut-price generic versions of Gilead's money-spinning combination hepatitis C treatment, Harvoni, on the domestic market.